1Sharma N,Andrews TC.Endothelial function as a therapeutic target in coronary artery disease[J].Curr Atheroscler Rep,2000,2(4):303-307.
2Cooke JP.The endothelium:a new target for therapy[J].Vasc Med,2000,5(1):49-53.
3Kinlay S,Ganz P.Role of Endothelial dysfunction in coronary artery disease and implications for therapy[J].Am J Cardiol,1997,80(9A):111-116.
4Koga N.Meaning of low-density lipoprotein-apheresis for hypercholesterolemic patients at high risk for recurrence of coronary heart disease[J].Therapeutic Apheresis,2002,6(5):372-380.
5Langer A,Constance C,Fodor JG,et al.Statin therapy and the management of acute coronary syndromes[J].Can J Cardiol,2003,19(8):921-927.
6Bogaty P,Hackett D,Davies G,et al.Vasoreactivity of the culprit lesion in unstable angina[J].Circulation,1994,90:5.
7Okumura K,Yasue H,Matsuyama K,et al.Effect of acetylcholine on the highly stenotic coronary artery:difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery[J].J Am Coll Cardiol,1992,19 (4):752-758.
8Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies,Part Ⅰ[J].Circulation,2003,108 (14):1664-1672.
9Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies,Part Ⅱ[J].Circulation,2003,108 (15):1772-1778.
10Jassim A1 Suwaidi,Shuichi Hamasaki,Stuart T.Higano,Rick A.Nishimura,David R.Holmes,Jr,and Amir Lerman.Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction[J].Circulation,2000,101(9):948-954.
